CLINICAL_TRIALS
trial_result
· 2015-10-07
Clinical Trial Update: An Open-Label Trial of Tocilizumab in Schizophrenia [Phase 1]
Summary
Open-label Phase 1 trial of tocilizumab in schizophrenia has completed; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brian Miller | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2015-10-07